A clinical stydy on the effectiveness of slow - resorbing collagen membrane barrier therapy to guide regeneration in mandibular class II furcations in human by Abolfazli N, Miremadi A, Khoshkhoonejad A

Get full text

An evaluation on the activity level of Aspartate aminotransferase and Alkaline phosphatase nzymes in peri-implant sulcus fluid by Paknegad M. Assistant Professor, Miremadi A. Associate Professor, Tabatabaei-e-Yazdi M. Associate Professor, Khodadad-e- Motarjemi M. Resident

Get full text

Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics by Li, X, Francies, H, Secrier, M, Perner, J, Miremadi, A, Galeano-Dalmau, N, Barendt, W, Letchford, L, Leyden, G, Goffin, E, Barthorpe, A, Lightfoot, H, Chen, E, Gilbert, J, Noorani, A, Devonshire, G, Bower, L, Grantham, A, Macrae, S, Grehan, N, Wedge, D, Fitzgerald, R, Garnett, M

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance by Secrier, M, Li, X, De Silva, N, Eldridge, MD, Contino, G, Bornschein, J, Macrae, S, Grehan, N, O'Donovan, M, Miremadi, A, Yang, T-P, Bower, L, Chettouh, H, Crawte, J, Galeano-Dalmau, N, Grabowska, A, Saunders, J, Underwood, T, Waddell, N, Barbour, AP, Nutzinger, B, Achilleos, A, Edwards, PAW, Lynch, AG, Tavaré, S, Fitzgerald, RC, Oesophageal Cancer Clinical And Molecular Stratification (Occams) Consortium

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma by Turkington, RC, Knight, LA, Blayney, JK, Secrier, M, Douglas, R, Parkes, EE, Sutton, EK, Stevenson, L, McManus, D, Halliday, S, McCavigan, AM, Logan, GE, Walker, SM, Steele, CJ, Perner, J, Bornschein, J, MacRae, S, Miremadi, A, McCarron, E, McQuaid, S, Arthur, K, James, JA, Eatock, MM, O'Neill, R, Noble, F, Underwood, TJ, Harkin, DP, Salto-Tellez, M, Fitzgerald, RC, Kennedy, RD, Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group